Résumé
Abstract 131
- Titre
- Malignant Plasma Cells Responsible for Multiple Myeloma Relapse Are Detectable and Survive Nine Days After High Dose Melphalan: Highlight of An Optimal Therapeutic Window ?
- Créateurs - sans rôle
- Anouk Caraux - INSERM U1040, Montpellier, FranceLaure Vincent - InsermJerome Moreaux - InsermGuilhem Requirand - Laboratory of Monitoring of Novel Therapeutics, Institute of Research in Biotherapy, Montpellier, FranceCaroline Bret - InsermJean-Luc Veyrune - Cellular Therapy Unit, CHU de Montpellier, Montpellier, FranceChristophe Duperray - Regional Cytometry Platform - Montpellier Rio-Imaging, Institute of Research in Biotherapy, MontpellierSalahedine Bouhya - Department of Clinical Hematology, CHU de Montpellier, Montpellier, FranceJean-Francois Rossi - Service d' Hematologie Clinique et Biotherapies, Chu de Montpellier-Hopital Saint-Eloi, Montpellier, FranceBernard Klein - Inserm
- Détails de publication
- Blood, Vol.118(21), pp.131-131
- Nombre de pages
- 1
- Identifiants
- 99138725009311
- Unité académique
- Institut de Génétique Humaine - IGH
- Langue
- English
- Type de ressource
- Journal article